UFSP2 and skeletal dysplasia: Ni and colleagues’ study findings suggested that variants observed in human skeletal dysplasia impact UFSP2’s catalytic activity, whereas the homozygous p.Val115Glu variant found associated with brain defects impacts the N-terminal domain, including protein stability and interaction with UFMylated targets.